Extreme hypo fractionation with biodegradable rectal spacer insertion
Topic Status Complete
Extreme hypo fractionation combined with biodegradable rectal spacer insertion for prostate cancer radiotherapy.
This report was prepared by Health Technology Wales on behalf of the Bevan Commission. It summarises the existing evidence on the technology of interest to support a Bevan health technology exemplar application.
Topic Exploration Report
Access our guidance
Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.